Clinical Trials Scientific Review Committee
The Clinical Trials Scientific Review Committee (CT-SRC) is responsible for scientific review of clinical protocols, including:
It monitors the progress of all institutional protocols to ensure:
-
That they adhere to the initial study design
-
That planned patient accrual is occurring
-
That planned stopping criteria are followed
-
That any observed toxicities are consistent with those expected
The CT-SRC has the authority to suspend or close protocols that fail to meet these requirements.